Vanguard Group’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $88.7M | Buy |
5,994,283
+980,263
| +20% | +$14.5M | ﹤0.01% | 1878 |
|
|
2025
Q1 | $89.9M | Sell |
5,014,020
-1,728,145
| -26% | -$31M | ﹤0.01% | 1842 |
|
|
2024
Q4 | $117M | Sell |
6,742,165
-159,985
| -2% | -$2.79M | ﹤0.01% | 1802 |
|
|
2024
Q3 | $96.6M | Buy |
6,902,150
+282,394
| +4% | +$3.95M | ﹤0.01% | 1886 |
|
|
2024
Q2 | $54.4M | Buy |
6,619,756
+353,927
| +6% | +$2.91M | ﹤0.01% | 2113 |
|
|
2024
Q1 | $48.3M | Buy |
6,265,829
+750,686
| +14% | +$5.79M | ﹤0.01% | 2183 |
|
|
2023
Q4 | $49.6M | Buy |
5,515,143
+847,685
| +18% | +$7.62M | ﹤0.01% | 2192 |
|
|
2023
Q3 | $41.7M | Buy |
4,667,458
+460,176
| +11% | +$4.11M | ﹤0.01% | 2214 |
|
|
2023
Q2 | $64.6M | Buy |
4,207,282
+222,688
| +6% | +$3.42M | ﹤0.01% | 2077 |
|
|
2023
Q1 | $89.6M | Buy |
3,984,594
+469,148
| +13% | +$10.6M | ﹤0.01% | 1880 |
|
|
2022
Q4 | $73.9M | Buy |
3,515,446
+133,836
| +4% | +$2.81M | ﹤0.01% | 1971 |
|
|
2022
Q3 | $83.3M | Buy |
3,381,610
+50,791
| +2% | +$1.25M | ﹤0.01% | 1908 |
|
|
2022
Q2 | $80.7M | Sell |
3,330,819
-516,716
| -13% | -$12.5M | ﹤0.01% | 1945 |
|
|
2022
Q1 | $99.2M | Sell |
3,847,535
-33,338
| -0.9% | -$859K | ﹤0.01% | 1945 |
|
|
2021
Q4 | $120M | Buy |
3,880,873
+15,392
| +0.4% | +$478K | ﹤0.01% | 1888 |
|
|
2021
Q3 | $93.7M | Buy |
3,865,481
+30,725
| +0.8% | +$745K | ﹤0.01% | 2010 |
|
|
2021
Q2 | $55.9M | Sell |
3,834,756
-166,832
| -4% | -$2.43M | ﹤0.01% | 2311 |
|
|
2021
Q1 | $99.9M | Buy |
4,001,588
+597,145
| +18% | +$14.9M | ﹤0.01% | 1947 |
|
|
2020
Q4 | $92.8M | Buy |
3,404,443
+181,611
| +6% | +$4.95M | ﹤0.01% | 1858 |
|
|
2020
Q3 | $59.5M | Buy |
3,222,832
+251,988
| +8% | +$4.65M | ﹤0.01% | 1918 |
|
|
2020
Q2 | $60.6M | Buy |
2,970,844
+396,250
| +15% | +$8.09M | ﹤0.01% | 1910 |
|
|
2020
Q1 | $37.6M | Buy |
2,574,594
+51,259
| +2% | +$748K | ﹤0.01% | 1992 |
|
|
2019
Q4 | $35.8M | Buy |
2,523,335
+156,639
| +7% | +$2.22M | ﹤0.01% | 2253 |
|
|
2019
Q3 | $27.4M | Buy |
2,366,696
+174,694
| +8% | +$2.02M | ﹤0.01% | 2323 |
|
|
2019
Q2 | $44M | Buy |
2,192,002
+73,736
| +3% | +$1.48M | ﹤0.01% | 2173 |
|
|
2019
Q1 | $47.9M | Buy |
2,118,266
+91,878
| +5% | +$2.08M | ﹤0.01% | 2105 |
|
|
2018
Q4 | $45.9M | Buy |
2,026,388
+97,786
| +5% | +$2.21M | ﹤0.01% | 2067 |
|
|
2018
Q3 | $55.4M | Buy |
1,928,602
+26,016
| +1% | +$747K | ﹤0.01% | 2094 |
|
|
2018
Q2 | $51.9M | Buy |
1,902,586
+134,701
| +8% | +$3.67M | ﹤0.01% | 2113 |
|
|
2018
Q1 | $39.5M | Buy |
1,767,885
+64,595
| +4% | +$1.44M | ﹤0.01% | 2193 |
|
|
2017
Q4 | $35.9M | Buy |
1,703,290
+16,446
| +1% | +$347K | ﹤0.01% | 2231 |
|
|
2017
Q3 | $42M | Buy |
1,686,844
+51,610
| +3% | +$1.28M | ﹤0.01% | 2126 |
|
|
2017
Q2 | $31.7M | Buy |
1,635,234
+125,695
| +8% | +$2.44M | ﹤0.01% | 2251 |
|
|
2017
Q1 | $27.9M | Buy |
1,509,539
+102,833
| +7% | +$1.9M | ﹤0.01% | 2293 |
|
|
2016
Q4 | $26.6M | Buy |
1,406,706
+74,223
| +6% | +$1.41M | ﹤0.01% | 2285 |
|
|
2016
Q3 | $29.8M | Buy |
1,332,483
+76,907
| +6% | +$1.72M | ﹤0.01% | 2176 |
|
|
2016
Q2 | $22.4M | Buy |
1,255,576
+69,097
| +6% | +$1.23M | ﹤0.01% | 2280 |
|
|
2016
Q1 | $16.2M | Buy |
1,186,479
+16,028
| +1% | +$219K | ﹤0.01% | 2385 |
|
|
2015
Q4 | $22.6M | Buy |
1,170,451
+19,152
| +2% | +$369K | ﹤0.01% | 2259 |
|
|
2015
Q3 | $23.3M | Buy |
1,151,299
+113,702
| +11% | +$2.3M | ﹤0.01% | 2215 |
|
|
2015
Q2 | $34.4M | Buy |
1,037,597
+316,464
| +44% | +$10.5M | ﹤0.01% | 2119 |
|
|
2015
Q1 | $17.3M | Buy |
721,133
+81,451
| +13% | +$1.95M | ﹤0.01% | 2383 |
|
|
2014
Q4 | $7.83M | Buy |
639,682
+232,663
| +57% | +$2.85M | ﹤0.01% | 2653 |
|
|
2014
Q3 | $3.67M | Buy |
407,019
+81,958
| +25% | +$739K | ﹤0.01% | 3000 |
|
|
2014
Q2 | $3.82M | Buy |
325,061
+49,979
| +18% | +$587K | ﹤0.01% | 2981 |
|
|
2014
Q1 | $5.85M | Buy |
+275,082
| New | +$5.85M | ﹤0.01% | 2749 |
|